However, retatrutide has not yet received regulatory approval from the MHRA, EMA, or FDA, meaning no licensed dosage currently exists
Considerations: While some individuals have reported positive results, its essential to consult with a healthcare professional or dermatologist before undergoing treatment, as individual reactions can vary
This isn't a sponsored article
On average weight loss in trials, retatrutides 12 mg result is larger than tirzepatides
Even without elevated liver enzymes, high VLDL indicates excessive hepatic fat production and likely some degree of fatty infiltration
Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors